It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Although widespread cortical thinning centered on the fronto-temporal regions in schizophrenia has been reported, the findings in at-risk mental state (ARMS) patients have been inconsistent. In addition, it remains unclear whether abnormalities of cortical thickness (CT) in ARMS individuals, if present, are related to their functional decline irrespective of future psychosis onset. In this multicenter study in Japan, T1-weighted magnetic resonance imaging was performed at baseline in 107 individuals with ARMS, who were subdivided into resilient (77, good functional outcome) and non-resilient (13, poor functional outcome) groups based on the change in Global Assessment of Functioning scores during 1-year follow-up, and 104 age- and sex-matched healthy controls recruited at four scanning sites. We measured the CT of the entire cortex and performed group comparisons using FreeSurfer software. The relationship between the CT and cognitive functioning was examined in an ARMS subsample (n = 70). ARMS individuals as a whole relative to healthy controls exhibited a significantly reduced CT, predominantly in the fronto-temporal regions, which was partly associated with cognitive impairments, and an increased CT in the left parietal and right occipital regions. Compared with resilient ARMS individuals, non-resilient ARMS individuals exhibited a significantly reduced CT of the right paracentral lobule. These findings suggest that ARMS individuals partly share CT abnormalities with patients with overt schizophrenia, potentially representing general vulnerability to psychopathology, and also support the role of cortical thinning in the paracentral lobule as a predictive biomarker for short-term functional decline in the ARMS population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Department of Neuropsychiatry, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X); University of Toyama, Research Center for Idling Brain Science, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X)
2 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Department of Neuropsychiatry, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X); Arisawabashi Hospital, Toyama, Japan (GRID:grid.267346.2)
3 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Department of Neuropsychiatry, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X); University of Toyama, Center for Health Care and Human Sciences, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X)
4 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Department of Neuropsychiatry, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X)
5 Toho University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan (GRID:grid.265050.4) (ISNI:0000 0000 9290 9879)
6 Toho University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan (GRID:grid.265050.4) (ISNI:0000 0000 9290 9879); Saiseikai Yokohamashi Tobu Hospital, Department of Psychiatry, Kanagawa, Japan (GRID:grid.265050.4)
7 Tohoku University Hospital, Department of Psychiatry, Sendai, Japan (GRID:grid.412757.2) (ISNI:0000 0004 0641 778X)
8 Osaki Citizen Hospital, Miyagi, Japan (GRID:grid.459827.5) (ISNI:0000 0004 0641 2751)
9 The University of Tokyo, Department of Neuropsychiatry, Graduate School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
10 The University of Tokyo, Department of Neuropsychiatry, Graduate School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, International Research Center for Neurointelligence (WRI-IRCN), UTIAS, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
11 The University of Tokyo, Department of Neuropsychiatry, Graduate School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Teikyo Heisei University, Graduate School of Clinical Psychology, Tokyo, Japan (GRID:grid.440938.2) (ISNI:0000 0000 9763 9732)
12 The University of Tokyo, Center for Evolutionary Cognitive Sciences (ECS), Graduate School of Art and Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
13 The University of Tokyo, Department of Neuropsychiatry, Graduate School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Center for Evolutionary Cognitive Sciences (ECS), Graduate School of Art and Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
14 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Department of Radiology, Toyama, Japan (GRID:grid.267346.2) (ISNI:0000 0001 2171 836X)
15 The University of Tokyo, Department of Neuropsychiatry, Graduate School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Hamamatsu University School of Medicine, Department of Psychiatry, Hamamatsu, Japan (GRID:grid.505613.4)
16 Kokoro no Clinic OASIS, Sendai, Japan (GRID:grid.505613.4)